Department of Gastroenterology, Sendai City Medical Center, Miyagi, Japan.
Dig Endosc. 2012 Jan;24(1):30-5. doi: 10.1111/j.1443-1661.2011.01161.x. Epub 2011 Jun 1.
To evaluate the usefulness of a modified technique of endoscopic papillectomy (EP) for lessening the occurrence of complications.
Indications for EP were adenoma or well-differentiated adenocarcinoma confined to the papilla of Vater (T1) without tumor spread into the bile/pancreatic duct. Sixteen patients underwent the modified technique, which consists of resection with the Endocut mode, followed by biliary/pancreatic sphincterotomy and stenting (Group A). Twelve patients who had undergone EP, using a cutting current, followed by pancreatic duct stenting were included as control (Group B). The frequency of complications and clinical outcomes were retrospectively compared between the two groups.
Sixteen patients had adenoma, and 12 had adenocarcinoma. Early complications occurred in 36% of all patients (hemorrhage, 7; cholangitis, 3; perforation, 2; cholecystitis, 1). The frequency of early complications in Group A was significantly lower than that in Group B (6% vs 75%, odds ratio [OR] 0.022, 95% confidence interval [CI], 0.0020-0.25). Late complications occurred in 18% of the patients (bile duct stone, 3; hemorrhage, 1; pancreatitis, 1). There was no significant difference in the late complication rate between Group A and Group B (19% vs 17%). Local recurrences were found in 14% of the patients, without a significant difference between Group A and Group B (19% vs 8%) during a mean follow-up period. All recurrent tumors were successfully treated with argon plasma coagulation.
The modified technique of EP for ampullary neoplasm contributed to lessening the occurrence of early complications. However, further refinement of this technique is necessary for improving the clinical outcome.
评估改良内镜乳头切除术(EP)技术在减少并发症发生方面的有效性。
EP 的适应证为局限于乳头的腺瘤或高分化腺癌(T1),且肿瘤未扩散至胆管/胰管。16 例患者接受改良技术治疗,该技术包括使用 Endocut 模式进行切除,然后进行胆管/胰管括约肌切开术和支架置入术(A 组)。12 例患者接受了 EP 治疗,使用切割电流,然后进行胰管支架置入,作为对照(B 组)。回顾性比较两组患者的并发症发生率和临床结局。
16 例患者为腺瘤,12 例患者为腺癌。所有患者中,早期并发症发生率为 36%(出血 7 例,胆管炎 3 例,穿孔 2 例,胆囊炎 1 例)。A 组的早期并发症发生率明显低于 B 组(6%比 75%,比值比 [OR] 0.022,95%置信区间 [CI] 0.0020-0.25)。18%的患者发生晚期并发症(胆管结石 3 例,出血 1 例,胰腺炎 1 例)。A 组和 B 组的晚期并发症发生率无显著差异(19%比 17%)。14%的患者出现局部复发,A 组和 B 组之间无显著差异(19%比 8%),平均随访期间。所有复发性肿瘤均成功采用氩等离子凝固治疗。
改良的 EP 技术治疗壶腹周围肿瘤有助于减少早期并发症的发生。然而,需要进一步改进该技术,以提高临床结局。